Electromed, Inc.

AMEX:ELMD

Medical - Devices

Healthcare
$23.40 +1.16%

+$0.43 today

Market cap
$191.27M
Beta
0.52
P/E (TTM)
30.5
EPS (TTM)
$1.23
52W Low $17.73High $40.00

Volume 0.05M

Average 0.06M

ELMD Depreciation & Amortization

Non-cash expense that spreads the cost of physical and intangible assets over their useful lives.

Electromed, Inc.AMEX: ELMD

Depreciation & Amortization · Q3 FY2026 · quarter ended Mar 2026

Depreciation & amortization grows, but more slowly than its trailing trend

Q3 FY2026 depreciation & amortization of $287K rose 1.4% year over year, behind the +21.9% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 11.2% from the prior quarter. Over 3 fiscal years it compounded at +23.1% a year.

Context

  • Depreciation & amortization amounted to 1.8% of revenue in FY2025, up 0.3 pp from a year earlier.
  • Depreciation & amortization increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +1.4% toward the trailing-twelve-month pace of +21.9%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$287K+11.2% QoQ
Last fiscal yearJun 2025
$1.17M+39.4% YoY
LTMMar 2026
$1.2M+21.9% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+1.4%——
1 year+39.4%——
3-year CAGR+23.1%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the income statement

Latest · FY2025
1.17M USD
Year-over-year change
+39.4%
4-year CAGR
+17.7%

Depreciation & Amortization vs competitors

How ELMD compares with its peers on the latest reported figures

  • ELMD's LTM Mar 2026 depreciation & amortization of $1.2M is the 5th highest of the 6 companies compared; the peer median is $29.62M.
  • Its year-over-year change of +21.9% is the highest of 6, against a peer median of +3.5%.
  • Depreciation & amortization amounts to 1.7% of revenue for ELMD, versus a peer median of 4.3%.
ELMD Competitors Peer median
Depreciation & Amortization for ELMD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AHCOAdaptHealth Corp.LTM Apr 2026$411.98M +12.3%-0.8%14.4%
RMDResMed Inc.LTM Jun 2026$244.15M +3.5%+7.3%4.3%
VMDViemed Healthcare, Inc.LTM Mar 2026$29.62M +15.3%+22.3%10.3%
TCMDTactile Systems Technology, Inc.LTM Mar 2026$6.56M -4.9%-22.8%1.9%
ELMDElectromed, Inc.LTM Mar 2026$1.2M +21.9%+23.1%1.7%
LUNGPulmonx CorporationLTM Mar 2026$996K -37.8%-11.4%1.1%
Peer median (excluding ELMD) $29.62M+3.5%-0.8%4.3%

Competitors are the stored peer set for ELMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Revenue35.76M41.66M48.07M54.72M64M
Cost of Revenue8.45M10.22M11.55M12.99M14.03M
Gross Profit27.31M31.44M36.52M41.73M49.97M
Gross Margin76.4%75.5%76.0%76.3%78.1%
Research & Development1.72M1.36M916K656K996K
Selling, General & Admin22.44M27.11M31.6M34.49M39.1M
Operating Expenses24.17M28.47M32.51M35.15M40.1M
Depreciation & Amortization610K628K613K841K1.17M
EBITDA3.78M3.63M4.7M7.88M11.46M
EBITDA Margin10.6%8.7%9.8%14.4%17.9%
Operating Income3.14M2.97M4.01M6.58M9.87M
Operating Margin8.8%7.1%8.3%12.0%15.4%
Interest Income39K25K78K455K624K
Interest Expense00000
Other Income / Expenses27K25K78K455K412K
Income Before Tax3.17M3M4.09M7.04M10.28M
Pre-Tax Margin8.9%7.2%8.5%12.9%16.1%
Income Tax Expense805K692K920K1.89M2.75M
Net Income2.36M2.31M3.17M5.15M7.54M
Net Margin6.6%5.5%6.6%9.4%11.8%
EPS (Basic)0.280.270.370.600.90
EPS (Diluted)0.270.260.360.580.86
Weighted Avg Shares8.57M8.47M8.46M8.56M8.33M
Weighted Avg Shares (Diluted)8.91M8.77M8.7M8.86M8.72M

Electromed, Inc.

AMEX:ELMD

Intrinsic Alpha fair value

Locked

Current Price

$23.40

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.